Overall Survival with Fruquintinib Versus Placebo after Adjusting for Subsequent Anticancer Therapy in Patients with Refractory Metastatic Colorectal Cancer in the FRESCO-2 Study.
Journal of Clinical Oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined